Endometrial Cancer Market Research Report, by Diagnosis (Pelvic Examination, Transvaginal Ultrasound, Endometrial Biopsy), Treatment (Hysterectomy, Radiation), End-User (Hospitals & Clinics, Ambulatory Surgical Centers) – Global Forecast Till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Endometrial Cancer Market, by Diagnosis

6.1 Introduction

6.2 Pelvic examination

6.3 Transvaginal ultrasound

6.4 Endometrial biopsy

6.5 Dilation and curettage (D&C)

6.6 Diagnostic laparoscopy

Chapter 7. Global Endometrial Cancer Market, by Treatment

7.1 Introduction

7.2 Hysterectomy Techniques

7.2.1 Open abdominal hysterectomy

7.2.2 Total vaginal hysterectomy

7.2.3 Total laparoscopic hysterectomy

7.2.4 Robotic hysterectomy

7.3 Radiation

7.3.1 External radiation

7.3.2 Internal radiation (brachytherapy)

7.4 Hormone therapy

7.4.1 Progestins

7.4.2 Tamoxifen

7.4.3 Luteinizing hormone-releasing hormone agonists

7.4.4 Aromatase inhibitors

7.5 Chemotherapy

7.5.1 Paclitaxel

7.5.2 Carboplatin

7.5.3 Doxorubicin

7.5.4 Cisplatin

7.6 Palliative care

Chapter 8. Global Endometrial Cancer market, by End-User

8.1 Introduction

8.2 Hospitals & Clinics

8.3 Ambulatory Surgical Centers

8.4 Diagnostic Centers

8.5 Gynecology Centers

8.6 Feminist health centers

Chapter 9. Global Endometrial Cancer Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia-Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Pfizer Inc

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials

11.2.4 Key Developments

11.1.5 SWOT Analysis

11.2 Koninklijke Philips N.V

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Boston Scientific Corporation

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 LUPIN

11.4.1 Company Overview

11.4.2 Type/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 PHYTON

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Bayer AG

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 CELGENE CORPORATION.

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Johnson & Johnson

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 CooperSurgical Inc.

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 LiNA Medical USA

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 CONCEPTUS INC

11.11.1 Overview

11.11.2 Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Hologic Inc.,

11.12.1 Overview

11.12.2 Type Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Karl Storz GmbH & Co. Kg

11.13.1 Overview

11.13.2 Type Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 GE Healthcare

11.14.1 Overview

11.14.2 Type Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Others

Chapter 12 Appendix

LIST OF TABLES

Table 1 Endometrial Cancer Market Industry Synopsis, 2020-2027

Table 2 Global Endometrial Cancer Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Endometrial Cancer Market, by Region, 2020-2027, (USD Million)

Table 4 Global Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table 5 Global Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 6 Global Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 7 North America Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table 8 North America Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 9 North America Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 10 US Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table 11 US Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 12 US Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 13 Canada Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table 14 Canada Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 15 Canada Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 16 South America Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table 17 South America Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 18 South America Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 19 Europe Endometrial Cancer Market, Diagnosis, 2020-2027, (USD Million)

Table 20 Europe Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 21 Europe Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 22 Western Europe Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table 23 Western Europe Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 24 Western Europe Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 25 Eastern Europe Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table26 Eastern Europe Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 27 Eastern Europe Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 28 Asia-Pacific Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table 29 Asia-Pacific Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 30 Asia-Pacific Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

Table 31 The Middle East & Africa Endometrial Cancer Market, by Diagnosis, 2020-2027, (USD Million)

Table 32 The Middle East & Africa Endometrial Cancer Market, by Treatment, 2020-2027, (USD Million)

Table 33 The Middle East & Africa Endometrial Cancer Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Endometrial Cancer Market

Figure 3 Market Dynamics for Global Endometrial Cancer Market

Figure 4 Global Endometrial Cancer Market Share, by Diagnosis 2020

Figure 5 Global Endometrial Cancer Market Share, by Treatment 2020

Figure 6 Global Endometrial Cancer Market Share, by End-User, 2020

Figure 7 Global Endometrial Cancer Market Share, by Region, 2020

Figure 8 North America Endometrial Cancer Market Share, by Country, 2020

Figure 9 Europe Endometrial Cancer Market Share, by Country, 2020

Figure 10 Asia-Pacific Endometrial Cancer Market Share, by Country, 2020

Figure 11 Middle East & Africa Endometrial Cancer Market Share, by Country, 2020

Figure 12 Global Endometrial Cancer Market: Company Share Analysis, 2020 (%)

Figure 13 PFIZER INC: Key Financials

Figure 14 PFIZER INC: Segmental Revenue

Figure 15 PFIZER INC: Geographical Revenue

Figure 16 Koninklijke Philips N.V: Key Financials

Figure 17 Koninklijke Philips N.V: Segmental Revenue

Figure 18 Koninklijke Philips N.V: Geographical Revenue

Figure 19 Boston Scientific Corporation: Key Financials

Figure 20 Boston Scientific Corporation: Segmental Revenue

Figure 21 Boston Scientific Corporation: Geographical Revenue

Figure 22 LUPIN: Key Financials

Figure 23 LUPIN: Segmental Revenue

Figure 24 LUPIN: Geographical Revenue

Figure 25 Bayer AG: Key Financials

Figure 26 Bayer AG: Segmental Revenue

Figure 27 Bayer AG: Geographical Revenue

Figure 28 PHYTON: Key Financials

Figure 29 PHYTON: Segmental Revenue

Figure 30 PHYTON: Geographical Revenue

Figure 31 CELGENE CORPORATION. : Key Financials

Figure 32 CELGENE CORPORATION. : Segmental Revenue

Figure 33 CELGENE CORPORATION. : Geographical Revenue

Figure 34 Johnson & Johnson: Key Financials

Figure 35 Johnson & Johnson: Segmental Revenue

Figure 36 Johnson & Johnson: Geographical Revenue

Figure 37 CooperSurgical Inc.: Key Financials

Figure 38 CooperSurgical Inc.: Segmental Revenue

Figure 39 CooperSurgical Inc.: Geographical Revenue

Figure 40 LiNA Medical USA: Key Financials

Figure 41 LiNA Medical USA: Segmental Revenue

Figure 42 LiNA Medical USA: Geographical Revenue

Figure 46 Hologic Inc.: Key Financials

Figure 47 Hologic Inc.: Segmental Revenue

Figure 48 Hologic Inc.: Geographical Revenue

Figure 49 Karl Storz GmbH & Co. Kg: Key Financials

Figure 50 Karl Storz GmbH & Co. Kg: Segmental Revenue

Figure 51 Karl Storz GmbH & Co. Kg: Geographical Revenue

Figure 52 C.R. Bard: Key Financials

Figure 53 C.R. Bard: Segmental Revenue

Figure 54 C.R. Bard: Geographical Revenue

Figure 55 GE Healthcare: Key Financials

Figure 56 GE Healthcare: Segmental Revenue

Figure 57 GE Healthcare: Geographical Revenue